GeneFerm Biotechnology Co Ltd Cash Flow Quality Index
GeneFerm Biotechnology Co Ltd cash flow quality index. GeneFerm Biotechnology Co Ltd (1796) has a Cash Flow Quality Index of 1.61x as of June 2025. Operating cash flow of NT$1.45 Million exceeds net income of NT$898.00K, indicating high earnings quality where cash backs reported profits. See GeneFerm Biotechnology Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of GeneFerm Biotechnology Co Ltd (2017–2023)
Cash flow quality index of GeneFerm Biotechnology Co Ltd from 2017 to 2023. Historical Cash Flow Quality Index for GeneFerm Biotechnology Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore GeneFerm Biotechnology Co Ltd (1796) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
GeneFerm Biotechnology Co Ltd Cash Flow Quality Index by Year (2017–2023)
GeneFerm Biotechnology Co Ltd cash flow quality index by year from 2017 to 2023. Year-by-year earnings quality comparison for GeneFerm Biotechnology Co Ltd. For the full cash flow conversion analysis, see how efficiently does GeneFerm Biotechnology Co Ltd generate cash.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.24x | NT$190.31 Million | NT$153.43 Million | ▲ +11.7% |
| 2022 | 1.11x | NT$122.43 Million | NT$110.21 Million | ▼ -30.3% |
| 2021 | 1.59x | NT$112.23 Million | NT$70.40 Million | ▼ -80.9% |
| 2020 | 8.33x | NT$56.42 Million | NT$6.77 Million | ▲ +104.0% |
| 2018 | 4.08x | NT$42.14 Million | NT$10.31 Million | ▲ +88.8% |
| 2017 | 2.16x | NT$61.08 Million | NT$28.23 Million | — |